<i>In silico</i> design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations
Yi Yang(First Hospital of Lanzhou University), Yusen Zhou(Southeast University), Jingjing Guo(Johns Hopkins University), Hong Yu(Kunming University of Science and Technology), Yan Guo(Institute of Microbiology), Xia Jin(Anhui Medical University), Guangyu Zhao(Academy of Military Medical Sciences), Lanying Du(Georgia State University), Shibo Jiang(Shanghai Medical College of Fudan University), Shihui Sun(Institute of Microbiology), Weilai Sun(Institute of Microbiology), Zhihua Kou(Institute of Microbiology), Jungfeng Li(Institute of Microbiology)
Cited by 156
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques
|The Journal of Experimental Medicine|1999|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759